about
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well...
Read More
5.60
0.23
(4.28%)
3.0M
XNAS Volume
XNAS 06 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Annexon Inc is on 14 Aug 2026 for the purpose of Annexon Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Annexon Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..